NewzIntel.com

Category: GlobeNewswire

  • MIL-OSI: Application for delisting of SDRs from Nasdaq Stockholm

    Source: GlobeNewswire (MIL-OSI)

    The management board of Northern Horizon Capital AS submitted today, 8 July 2025, an application to Nasdaq Stockholm for the delisting of the SDRs. The application was submitted in connection with the planned delisting of SDRs from Nasdaq Stockholm (notice of termination https://view.news.eu.nasdaq.com/view?id=1354309&lang=en) in accordance with the resolution of the fund manager dated 13 February 2025.

    The last day of trading in the SDR on Nasdaq Stockholm is planned to be on 8 October 2025.

    For additional information, please contact:

    Tarmo Karotam
    Baltic Horizon Fund manager
    E-mail tarmo.karotam@nh-cap.com
    www.baltichorizon.com

    The Fund is a registered contractual public closed-end real estate fund that is managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS. 

    Distribution: GlobeNewswire, Nasdaq Tallinn, Nasdaq Stockholm, www.baltichorizon.com

    To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also follow Baltic Horizon Fund on www.baltichorizon.com and on LinkedIn, Facebook, X and YouTube.

    The MIL Network –

  • MIL-OSI: UPDATE — Intermex Launches a new Remittance-as-a-Service (RaaS) Platform to Help Businesses Simplify Cross-Border Payments

    Source: GlobeNewswire (MIL-OSI)

    MIAMI, July 08, 2025 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), a leading money remittance provider to Latin America and the Caribbean, today announced the launch of its fully redesigned Remittance-as-a-Service (RaaS) platform. The upgraded service gives businesses a straightforward way to embed fast, secure cross-border money transfers into their own customer experiences.

    A growing number of companies – from innovative U.S. fintechs to well-established payment providers – are already harnessing Intermex’s Remittance-as-a-Service platform to unlock new cross-border revenue streams.

    Through Intermex’s RaaS platform, companies can introduce their own branded person-to-person and business-to-person payment services to eligible markets including Mexico, Guatemala, Honduras, the Dominican Republic, and El Salvador, as well as select countries in Southeast Asia, the European Union, and Africa.

    “Businesses want to innovate and expand quickly, but hurdles like technology development, licensing, and regulatory compliance often slow them down,” said Marcelo Theodoro, Chief Digital, Product & Marketing Officer at Intermex. “Our RaaS platform helps remove those barriers, giving partners a turnkey solution built on decades of experience and one of the strongest payout networks in Latin America.”

    The enhanced platform offers a customizable system that lets businesses create branded customer experiences across WhatsApp, mobile apps, and the web. The service is supported by appropriate licensing across U.S. jurisdictions, incorporating required know your customers and anti-money laundering compliance measures. Companies gain access to one of the largest payout networks in Latin America, supporting cash pickups, home deliveries, and direct bank deposits. The solution also provides integrated payment services, merchant account management, chargeback support, and advanced anti-fraud tools. Additionally, partners benefit from 24/7 bilingual customer support, business insights, and ongoing strategic guidance.

    “Our partners don’t have to build everything from scratch,” Theodoro added. “Through a simple API, we provide the infrastructure, licenses, payout networks, and even the support teams they need. Whether you’re a fintech, an employer, or a loyalty platform, we’re ready to help businesses move money across borders.”

    Companies interested in partnering with Intermex can learn more at www.intermexonline.com/partner-with-us#/.

    About Intermex
    Founded in 1994, Intermex applies proprietary technology to facilitate money transfers from select locations including the United States, Canada, Spain, Italy, the United Kingdom, and Germany to more than 60 countries, where available and subject to applicable regulations. The company facilitates digital money movement through its website and mobile app, as well as through a vast network of retail agents and company-operated stores. Headquartered in Miami, Florida, Intermex also operates international offices in Puebla, Mexico; Guatemala City, Guatemala; London, England; and Madrid, Spain. Learn more at www.intermexonline.com.

    Investor Relations Contact:
    Alex Sadowski
    Investor Relations Coordinator
    ir@intermexusa.com
    305-671-8000

    The MIL Network –

  • MIL-OSI: UPDATE — Intermex Launches a new Remittance-as-a-Service (RaaS) Platform to Help Businesses Simplify Cross-Border Payments

    Source: GlobeNewswire (MIL-OSI)

    MIAMI, July 08, 2025 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), a leading money remittance provider to Latin America and the Caribbean, today announced the launch of its fully redesigned Remittance-as-a-Service (RaaS) platform. The upgraded service gives businesses a straightforward way to embed fast, secure cross-border money transfers into their own customer experiences.

    A growing number of companies – from innovative U.S. fintechs to well-established payment providers – are already harnessing Intermex’s Remittance-as-a-Service platform to unlock new cross-border revenue streams.

    Through Intermex’s RaaS platform, companies can introduce their own branded person-to-person and business-to-person payment services to eligible markets including Mexico, Guatemala, Honduras, the Dominican Republic, and El Salvador, as well as select countries in Southeast Asia, the European Union, and Africa.

    “Businesses want to innovate and expand quickly, but hurdles like technology development, licensing, and regulatory compliance often slow them down,” said Marcelo Theodoro, Chief Digital, Product & Marketing Officer at Intermex. “Our RaaS platform helps remove those barriers, giving partners a turnkey solution built on decades of experience and one of the strongest payout networks in Latin America.”

    The enhanced platform offers a customizable system that lets businesses create branded customer experiences across WhatsApp, mobile apps, and the web. The service is supported by appropriate licensing across U.S. jurisdictions, incorporating required know your customers and anti-money laundering compliance measures. Companies gain access to one of the largest payout networks in Latin America, supporting cash pickups, home deliveries, and direct bank deposits. The solution also provides integrated payment services, merchant account management, chargeback support, and advanced anti-fraud tools. Additionally, partners benefit from 24/7 bilingual customer support, business insights, and ongoing strategic guidance.

    “Our partners don’t have to build everything from scratch,” Theodoro added. “Through a simple API, we provide the infrastructure, licenses, payout networks, and even the support teams they need. Whether you’re a fintech, an employer, or a loyalty platform, we’re ready to help businesses move money across borders.”

    Companies interested in partnering with Intermex can learn more at www.intermexonline.com/partner-with-us#/.

    About Intermex
    Founded in 1994, Intermex applies proprietary technology to facilitate money transfers from select locations including the United States, Canada, Spain, Italy, the United Kingdom, and Germany to more than 60 countries, where available and subject to applicable regulations. The company facilitates digital money movement through its website and mobile app, as well as through a vast network of retail agents and company-operated stores. Headquartered in Miami, Florida, Intermex also operates international offices in Puebla, Mexico; Guatemala City, Guatemala; London, England; and Madrid, Spain. Learn more at www.intermexonline.com.

    Investor Relations Contact:
    Alex Sadowski
    Investor Relations Coordinator
    ir@intermexusa.com
    305-671-8000

    The MIL Network –

  • MIL-OSI: BluSky AI Inc. Secures First Site with 9.3MW to Launch Flagship Data Center in Central, Utah

    Source: GlobeNewswire (MIL-OSI)

    Salt Lake City Utah, July 08, 2025 (GLOBE NEWSWIRE) — BluSky AI Inc. (OTC: BSAI), (“BluSky AI” or the “Company”), a next-generation developer of modular AI data center infrastructure, is proud to announce the acquisition of its first operational site, securing a total of 9.3 megawatts (MW) of power to support its flagship data center project in Central, Utah.

    On June 30, 2025, BluSky AI entered into a definitive Acquisition and Power Assignment Agreement with Digital Asset Management, LLC (“DAM”), a Wyoming-based infrastructure partner. Under the agreement, DAM assigned to BluSky AI its exclusive right to utilize 9.3 MW of grid-interconnected power at a highly competitive rate, subject to standard adjustments. This power commitment will support BluSky AI’s long-term operations at the Milford site.

    In consideration for the power rights, BluSky AI issued 20 million shares of restricted common stock to DAM. The agreement spans the full operational life of the Utah data center project, ensuring long-term energy stability and cost efficiency.

    Simultaneously, BluSky AI executed a Ground Lease with an Option to Purchase with Wild Mustang Ventures LLC, securing 51.6 acres of land in Central, Utah. The lease, which runs for an initial two-year term, includes an annual base rent of $90,000, which will accrue until the earlier of lease expiration or BluSky’s exercise of its purchase option.

    With this dual milestone, BluSky AI now controls 9.3 MW of power capacity, including additional grid access beyond the commitment, positioning the Company to rapidly deploy its modular AI compute infrastructure.

    “This is a foundational moment for BluSky AI,” said Trent D’Ambrosio, CEO of BluSky AI Inc. “Securing long-term, low-cost power and a strategic land position in Central Utah gives us the runway to scale our AI infrastructure with sustainability and precision. It’s the first step in a bold vision to provide access to compute and power the future of intelligent systems.”

    Trent D’Ambrosio
    CEO, BluSky AI Inc.
    trentdambrosio@bluskyaidatacenters.com
    www.bluskyaidatacenters.com

    About BluSky AI Inc.

    Headquartered in Salt Lake City, Utah, BluSky AI Inc. delivers modular, rapidly deployable data center infrastructure purpose-built for artificial intelligence. These next generation scalable AI Factories provide speed-to-market, and energy optimization for entities requiring high-performance infrastructure to support machine learning workloads. BluSky AI empowers small, mid-sized, enterprise, and academic partners from start-up to scale-up to drive innovation without compromise.

    Forward-Looking Statements:

    This news release includes certain forward-looking statements or information. All statements other than statements of historical fact included in this release are forward-looking statements that involve various risks and uncertainties.  Forward-looking statements in this news release include statements with respect to the potential impact for the Company. There can be no assurance statements will prove to be accurate and actual results and future events could differ materially from anticipated in such statements.

    BluSky AI Inc. disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events except as required by applicable securities legislation.

    The MIL Network –

  • MIL-OSI: BluSky AI Inc. Secures First Site with 9.3MW to Launch Flagship Data Center in Central, Utah

    Source: GlobeNewswire (MIL-OSI)

    Salt Lake City Utah, July 08, 2025 (GLOBE NEWSWIRE) — BluSky AI Inc. (OTC: BSAI), (“BluSky AI” or the “Company”), a next-generation developer of modular AI data center infrastructure, is proud to announce the acquisition of its first operational site, securing a total of 9.3 megawatts (MW) of power to support its flagship data center project in Central, Utah.

    On June 30, 2025, BluSky AI entered into a definitive Acquisition and Power Assignment Agreement with Digital Asset Management, LLC (“DAM”), a Wyoming-based infrastructure partner. Under the agreement, DAM assigned to BluSky AI its exclusive right to utilize 9.3 MW of grid-interconnected power at a highly competitive rate, subject to standard adjustments. This power commitment will support BluSky AI’s long-term operations at the Milford site.

    In consideration for the power rights, BluSky AI issued 20 million shares of restricted common stock to DAM. The agreement spans the full operational life of the Utah data center project, ensuring long-term energy stability and cost efficiency.

    Simultaneously, BluSky AI executed a Ground Lease with an Option to Purchase with Wild Mustang Ventures LLC, securing 51.6 acres of land in Central, Utah. The lease, which runs for an initial two-year term, includes an annual base rent of $90,000, which will accrue until the earlier of lease expiration or BluSky’s exercise of its purchase option.

    With this dual milestone, BluSky AI now controls 9.3 MW of power capacity, including additional grid access beyond the commitment, positioning the Company to rapidly deploy its modular AI compute infrastructure.

    “This is a foundational moment for BluSky AI,” said Trent D’Ambrosio, CEO of BluSky AI Inc. “Securing long-term, low-cost power and a strategic land position in Central Utah gives us the runway to scale our AI infrastructure with sustainability and precision. It’s the first step in a bold vision to provide access to compute and power the future of intelligent systems.”

    Trent D’Ambrosio
    CEO, BluSky AI Inc.
    trentdambrosio@bluskyaidatacenters.com
    www.bluskyaidatacenters.com

    About BluSky AI Inc.

    Headquartered in Salt Lake City, Utah, BluSky AI Inc. delivers modular, rapidly deployable data center infrastructure purpose-built for artificial intelligence. These next generation scalable AI Factories provide speed-to-market, and energy optimization for entities requiring high-performance infrastructure to support machine learning workloads. BluSky AI empowers small, mid-sized, enterprise, and academic partners from start-up to scale-up to drive innovation without compromise.

    Forward-Looking Statements:

    This news release includes certain forward-looking statements or information. All statements other than statements of historical fact included in this release are forward-looking statements that involve various risks and uncertainties.  Forward-looking statements in this news release include statements with respect to the potential impact for the Company. There can be no assurance statements will prove to be accurate and actual results and future events could differ materially from anticipated in such statements.

    BluSky AI Inc. disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events except as required by applicable securities legislation.

    The MIL Network –

  • MIL-OSI: Graphenix Development Inc. Awarded $100,000 SuperBoost Grant to Extend Cycle Life of Silicon Anode Lithium-Ion Batteries

    Source: GlobeNewswire (MIL-OSI)

    ROCHESTER, N.Y., July 08, 2025 (GLOBE NEWSWIRE) — Graphenix Development Inc. (GDI), a Rochester-based battery materials company, has been awarded a $100,000 SuperBoost grant from the National Science Foundation’s Energy Storage Engine in Upstate New York. The funding will support GDI’s efforts to extend the cycle life of its 100% silicon anode technology through the development of a prelithiation method designed to improve battery durability and performance across sectors including defense, automotive, medical and wearable technologies.

    GDI’s silicon anodes are fabricated using a solvent-free, plasma-enhanced chemical vapor deposition (PECVD) process. The result is a high energy-density electrode that eliminates graphite, powders, binders and toxic solvents — simplifying the manufacturing process and enabling a more sustainable, domestically sourced battery supply chain. The SuperBoost project will focus on integrating lithium iron oxide (LFO) into high-nickel cathodes to enable in situ prelithiation, a method that compensates for lithium loss during early charging cycles and helps extend battery life.

    National security and defense applications are a key focus of GDI’s work, particularly as the United States seeks to secure domestic supply chains and enhance energy resilience. The project builds on GDI’s existing industry collaborations, including a next-generation tactical battery initiative with a U.S.-based defense-sector customer and ongoing evaluations with automotive manufacturers.

    Experimental work will take place at the Rochester Institute of Technology (RIT) Battery Development Center, where GDI will validate LFO-based cathode formulations in coin cells before scaling to pouch cells assembled in RIT’s dry room facility.

    “This support from the NSF Energy Storage Engine will allow us to advance a key part of our technology roadmap,” said Robert Anstey, CEO of GDI. “Improving cycle life through prelithiation will further enhance GDI’s performance advantages in Li-ion. We have already proven >30% energy density, and 15-minute fast charging with defense cell makers. Extending cycle life further and improving durability will be particularly important for dual-use applications.”

    Fernando Gómez-Baquero, director of the Translation Pillar at the NSF Energy Storage Engine, emphasized the role of the grant in strengthening battery innovation in the region. “Cycle life is a major challenge for silicon anode batteries,” he said. “GDI’s approach to addressing this through prelithiation aligns with the Engine’s mission to accelerate high-impact technologies that bolster U.S. manufacturing and national security.”

    Meera Sampath, CEO of the NSF Energy Storage Engine, noted the broader goals of the SuperBoost initiative. “Our SuperBoost program is designed to reduce the time it takes to bring cutting-edge energy storage technologies to market — from five years to fewer than two,” said Sampath. “GDI’s work reflects the kind of advanced materials innovation that not only strengthens domestic supply chains but also supports critical defense applications, positioning upstate New York as a center for next-generation battery solutions.”

    About Graphenix Development Inc.

    Graphenix Development Inc. (GDI) is developing a next-generation battery anode platform based on 100% silicon. Its proprietary PECVD fabrication process eliminates graphite, solvents, and binders, resulting in a cleaner, more scalable pathway to high energy-density lithium-ion batteries. Proving in 3rd party testing to increase energy density by >30% up to 900Wh/L, and enabling hundreds of repeated <15-minute charging cycles. GDI is headquartered in Rochester, NY. Learn more at www.gdinrg.com.

    Contact:
    Robert Anstey
    CEO and Founder
    Graphenix Development Inc.
    rob.anstey@graphnx.com

    About the NSF Energy Storage Engine in Upstate New York

    The NSF Energy Storage Engine in Upstate New York, led by Binghamton University, is a National Science Foundation-funded, place-based innovation program. The coalition of 40+ academic, industry, nonprofit, state, and community organizations includes Cornell University, Rochester Institute of Technology, Syracuse University, Griffiss Institute, Launch-NY and NY-BEST as core partners. The Engine advances next-gen battery technology development and manufacturing to drive economic growth and bolster national security. Its vision is to transform upstate New York into America’s Battery Capital.

    For more information on the NSF Energy Storage Engine in Upstate New York, visit https://upstatenyengine.org/.

    Contact:
    Fernando Gómez-Baquero Ph.D.
    Translation Pillar Director
    NSF Upstate New York Energy Storage Engine
    fernando@cornell.edu

    The MIL Network –

  • MIL-OSI: GoldenMining Launches Enhanced AI-Powered Cloud Mining Platform as Crypto Infrastructure Advances

    Source: GlobeNewswire (MIL-OSI)

    New York, July 08, 2025 (GLOBE NEWSWIRE) —

    Amid renewed momentum in the digital asset sector and a resurgence in tech equities, GoldenMining has unveiled an upgraded version of its automated crypto mining platform, leveraging intelligent computing technologies to optimize cloud-based operations. The launch comes as industry players focus on scalable, infrastructure-driven innovations in the blockchain space.

    GoldenMining operates a globally distributed network of data centers that power its AI-driven mining ecosystem. The platform supports real-time resource allocation and automatic switching between multiple cryptocurrency networks, including Bitcoin (BTC), Ethereum (ETH), XRP, Dogecoin (DOGE), and others. The goal is to enable users to engage in mining operations without the need for hardware, technical expertise, or on-site management.

    “We’re advancing mining accessibility through automation,” said a GoldenMining spokesperson. “Our platform is built to dynamically respond to network activity and adjust mining strategies accordingly—offering an efficient, hands-off entry point into crypto infrastructure.”

    Popular contract recommendations

    contract days Investment Amount Contract Rewards Total income
    Elphapex DG1+ 2 $100 $3 $106
    Bitmain S23 Hyd 5 $650 $42.25 $692.25
    AntminerL917GH 12 $1800 $287.28 $2087.28
    L916GH 30 $4500 $1890 $6390
    ElphaPex DG Hydro1 30 $7800 $3276 $11076
    Elphapex DG2 45 $12000 $180 $20100

    It only takes four steps to start:

    1. Register an account and get a trial bonus for new users; for more activities, please consult the official website: (www.GoldenMining.com)

    2. Select and activate the contract, and the cloud system automatically runs the mining machine;

    3. Receive daily profits: Daily profits will be automatically calculated and sent to your account. When your balance reaches 100. You can withdraw at any time or choose to automatically reinvest and enjoy compound interest

    4. Multi-currency parallel mining: In addition to BTC, GoldenMining supports DOGE, LTC, ETH, USDT, XRP and other currency mining. When XRP trading is active, it can automatically switch mining currencies to capture the increased bonus.

    Key Features of the GoldenMining Platform:

    • AI-Based Power Scheduling: Continuously monitors network difficulty and transaction activity to optimize mining allocation.
    • Multi-Currency Support: Enables simultaneous mining of various digital assets with automated switching based on network conditions.
    • Decentralized Infrastructure: Operates 13+ high-performance data centers worldwide to ensure system reliability and uptime.
    • Energy-Efficient Operations: Utilizes optimized hardware configurations and scalable infrastructure with an emphasis on sustainability.
    • User-Friendly Interface: Accessible via web and mobile platforms for real-time monitoring and system management.

    GoldenMining’s latest platform update is aligned with broader trends in the crypto industry, where automation and intelligence are becoming key pillars of next-generation blockchain participation. The company has also announced ongoing expansion of its mining infrastructure and plans to support additional payment channels and smart contract integrations in the near future.

    About GoldenMining

    GoldenMining is a global provider of cloud-based mining services, committed to developing accessible and fully automated solutions for digital asset enthusiasts. With users in over 100 countries and a growing network of international data centers, the company aims to simplify crypto infrastructure engagement at scale.

    Official Website: www.GoldenMining.com

    Disclaimer: The information provided in this press release does not constitute an investment solicitation, nor does it constitute investment advice, financial advice, or trading recommendations. Cryptocurrency mining and staking involve risks and the possibility of losing funds. It is strongly recommended that you perform due diligence before investing or trading in cryptocurrencies and securities, including consulting a professional financial advisor.

    The MIL Network –

  • MIL-OSI: Surfshark partners up with MSI to grant more digital perks

    Source: GlobeNewswire (MIL-OSI)

    Surfshark, a cybersecurity company building the most beloved security products for everyone, announces a new partnership with MSI, a leader in gaming and high-performance computing solutions, to provide more digital perks to the members of the MSI Reward Program. Now, the program members can experience a free trial of Surfshark’s most popular VPN subscription plan. 

    “In today’s world, where digital footprints are constantly tracked and data breaches are on the rise, people more than ever seek tools that can help to reclaim digital privacy and strengthen online security. A VPN encrypts internet traffic and masks a person’s IP address, making it more secure to stay online. Therefore, this collaboration brings exciting opportunities for MSI users to enhance their online experience with Surfshark’s security and privacy,” says Justas Pukys, Sr. Product Manager at Surfshark.

    Members of the MSI Reward Program can redeem a free 1-month trial of Surfshark One with just 25 points. The MSI Reward Program is a loyalty platform where MSI users can earn points by registering products, completing tasks, or participating in events, and redeem those points for exclusive gifts, discounts, and digital perks, like Surfshark.

    “We understand how increasingly important online security is to our users,” says Vera Chen from MSI Partnership Alliance Marketing. “This partnership with Surfshark underlines our commitment not only to delivering high-performance hardware and innovation, but also to protecting user privacy and data. Whether gaming, creating content, or tackling demanding workloads, our users can now enjoy peace of mind knowing their internet experience is safeguarded by Surfshark’s leading VPN service.”

    Also, extra perks are provided for shoppers in Europe. Until July 22, 2025, customers who purchase selected items during the MSI summer sale on the MSI Official eShop can enjoy up to 30% off on selected products, and a one-month trial of Surfshark One included with selected MSI products. Special offers are provided for Germany, France, Spain, and Poland.

    For more information, read here.

    ABOUT SURFSHARK

    Surfshark is a cybersecurity company offering products including an audited VPN, certified antivirus, data leak warning system, private search engine, and tool for generating an online identity. Recognized as a leading VPN by CNET and TechRadar, Surfshark has also been featured on the FT1000: Europe’s Fastest Growing Companies ranking. Headquartered in the Netherlands, Surfshark has offices in Lithuania and Poland. For information on Surfshark’s operations and highlights, read our Annual Wrap-up. For information about Surfshark’s previous independent verifications and certifications, visit our Trust Center.

    ABOUT MSI

    MSI (Micro-Star International) is a world leader in gaming, content creation, business & productivity, and AIoT solutions. Operating in over 120 countries, MSI is renowned for its high-quality laptops, desktops, graphics cards, motherboards, monitors, and more. Driven by innovation and a passion for technology, MSI is committed to delivering the best user experiences through cutting-edge R&D, intuitive design, and exceptional product quality. Discover more about MSI at msi.com.

    Attachment

    The MIL Network –

  • MIL-OSI: Boralex will release its 2025 second quarter financial results on August 8, at 11 a.m.

    Source: GlobeNewswire (MIL-OSI)

    MONTREAL, July 08, 2025 (GLOBE NEWSWIRE) — Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2025 second quarter results will take place on Friday, August 8, 2025, at 11 a.m.

    Financial analysts and investors are invited to attend a conference call during which the financial results will be presented.

    Date and time

    Friday, August 8, 2025, at 11 a.m. ET

    To attend the conference

    Webcast link: https://edge.media-server.com/mmc/p/ceviggr3

    To attend the event by phone: Click here to register for the earnings call. Once you have completed your registration, you will receive a confirmation email containing the link and your personal PIN to connect to the call. If you lose this link and your PIN, you will be able to register again. You must register if you wish to attend the call by phone.

    Media and other interested individuals are invited to listen to the conference and view the presentation which will be broadcasted live. A full replay will also be available on Boralex’s website until August 8, 2026.

    The financial information will be released through a press release and on Boralex’s website on August 8, 2025, at 7 a.m.

    About Boralex

    At Boralex, we have been providing affordable renewable energy accessible to everyone for over 30 years. As a leader in the Canadian market and France’s largest independent producer of onshore wind power, we also have facilities in the United States and development projects in the United Kingdom. Over the past five years, our installed capacity has increased by more than 50% to 3.2 GW. We are developing a portfolio of projects in development and construction of more than 8 GW in wind, solar and storage projects, guided by our values and our corporate social responsibility (CSR) approach. Recognized as Best Corporate Citizen in Canada by Corporate Knights, Boralex is actively participating in the fight against global warming. Thanks to our fearlessness, discipline, expertise and diversity, we continue to be an industry leader. Boralex’s shares are listed on the Toronto Stock Exchange under the ticker symbol BLX.

    For more information, visit boralex.com or sedarplus.com. Follow us on Facebook, LinkedIn and Instagram.

    For more information

    MEDIA INVESTOR RELATIONS
    Camille Laventure
    Senior Advisor, Public Affairs and External Communications

    Boralex Inc.

    438-883-8580
    camille.laventure@boralex.com

    		 Stéphane Milot
    Vice President, Investor Relations and Financial Planning and Analysis

    Boralex Inc.

    514-213-1045
    stephane.milot@boralex.com
       

    The MIL Network –

  • MIL-OSI: Flexera Announces Winners of the 2025 Technology Intelligence Awards

    Source: GlobeNewswire (MIL-OSI)

    ITASCA, Ill., July 08, 2025 (GLOBE NEWSWIRE) — Flexera, the global leader in technology spend and risk management, today announces the winners of the fifth annual Technology Intelligence Awards. The awards recognize organizations that have demonstrated exceptional achievements in leveraging IT Asset Management (ITAM), FinOps and SaaS Management to drive growth, innovation and positive impact. 

    “Our customers continue to redefine what’s possible and drive innovation across ITAM, FinOps and SaaS Management,” said Roy Ritthaler, Executive Vice President of Customer Value at Flexera. “The Technology Intelligence Awards celebrate these remarkable achievements, recognizing their relentless focus on optimizing technology spend, reducing risk, and making smarter, data-driven decisions. This year’s winners demonstrate a shift toward a holistic approach, integrating cloud and SaaS solutions, treating them as interconnected parts of an optimization strategy.”

    The award entries from Flexera customers worldwide highlighted key industry trends including:

    • The evident adoption of policy-driven automation and machine learning, showing transitions from pilots to production for cost savings and enhanced IT visibility.
    • A focus on purpose-led optimization and modernization, aligning ITAM with broader business goals.
    • The FinOps submissions indicated a rise in financial accountability in engineering, with budgets linked to team KPIs, cost awareness integrated into workflows, and greater ownership of spend across technical teams.

    “We’re honored to receive the Breakthrough Award from Flexera,” said Michał Sawicki, Senior Contract and License Lead at Heineken. “This recognition reflects the dedication and innovation of our Software Asset Management team at Heineken, and the strong partnership we’ve built with Flexera. Thank you for supporting our journey toward a smarter, more efficient and innovative software landscape.”

    This year’s winners and honorable mentions are:

    Breakthrough of the Year: Recognizing the submission that redefined what’s possible through innovation, intelligence, and measurable impact.

    Impact of the Year: Recognizing an organization that has achieved significant, business-wide impact using any Flexera solution—or a combination of multiple solutions. 


    Innovation of the Year:     Recognizing organizations that have used Flexera solutions in a new or creative way to solve a problem. 


    ITAM Excellence:     Recognizing outstanding achievement in ITAM using Flexera One ITAM or SAM on Snow Atlas. 


    SaaS Management Excellence:     Recognizing organizations that have successfully optimized SaaS management using Flexera One SaaS Manager or Snow SaaS Management. 


    FinOps Excellence:     Recognizing organizations leading the way in FinOps by maximizing ROI from cloud spend. 

    Technology for Good: Recognizes organizations that leverage Flexera’s technology solutions to drive social or environmental impact. 


    Rookie of the Year:     Recognizes a new Flexera customer that has successfully implemented any Flexera solutions in the past year (starting May 2024). 

    This year’s awards were evaluated by an independent panel of industry analysts and practitioners, which included:

    Winners were selected based on the quality and clarity of their submissions, tangible metrics demonstrating success, and measurable business outcomes. The 2025 Technology Intelligence Awards recognize fifteen customers from the US, UK, Switzerland, Kenya, Turkey, India and Australia.

    For more information on the award winners and categories, please visit: https://www.flexera.com/customer-success/awards.

    Follow Flexera 

    About Flexera

    Flexera helps organizations understand and maximize the value of their technology, saving billions of dollars in wasted spend. Powered by the Flexera Technology Intelligence Platform, our award-winning IT asset management, FinOps and SaaS management solutions provide comprehensive visibility and actionable insights on an organization’s entire IT ecosystem. This intelligence enables IT, finance, procurement, FinOps and cloud teams to address skyrocketing costs, optimize spend, mitigate risk and identify opportunities to create positive business outcomes. More than 50,000 global organizations rely on Flexera and its Technopedia reference library, the largest repository of technology asset data. Learn more at flexera.com.

    For more information, contact:

    Ciri Haugh
    Flexera
    publicrelations@flexera.com

    The MIL Network –

  • MIL-OSI: Leadership Transition at WorldTrips

    Source: GlobeNewswire (MIL-OSI)

    HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) —
    Tokio Marine HCC, based in Houston, Texas, today announced a key leadership transition, effective July 1, 2025, at its travel-focused subsidiary, WorldTrips, a leading provider of travel insurance located in Carmel, Indiana.

    After years of dedicated service and transformational leadership, Mark Carney will transition from his role as CEO of WorldTrips to become its Chairman, where he will continue to shape the company’s strategic direction and support long-term growth initiatives.

    At the same time, Philip Hsia has been appointed CEO of WorldTrips. A proven leader with deep global experience, Hsia has led Tokio Marine HCC’s Global Travel Group, including oversight responsibility of WorldTrips, since 2018. He has been an integral part of the organization’s success and is well-positioned to lead the company through its next phase of innovation and expansion.

    Susan Rivera, Tokio Marine HCC’s CEO, shared the following statement:

    “Mark’s leadership has been foundational to the growth and resilience of WorldTrips. Under his guidance, the company navigated unprecedented challenges, including the global pandemic, and recently completed launching our Cayman Islands insurance operation, positioning WorldTrips for greater flexibility and future scalability.

    I am deeply grateful for Mark’s continued commitment in his new role as Chairman. His focus on long-term strategy and leadership development will remain a vital part of WorldTrips’ ongoing success.

    I’m equally excited to welcome Philip Hsia as the next CEO of WorldTrips. Phil brings proven strategic and managerial expertise with a global perspective. He has our full confidence and support as he steps into this role.”

    The transition follows a strategic succession planning process initiated earlier this year. With the foundation in place, including a broadened product portfolio and enhanced operational agility, WorldTrips is primed to accelerate its mission of helping travelers explore the world with confidence.

    “WorldTrips is entering an exciting new chapter,” added Rivera. “With Mark and Phil in their new roles, I am confident the company will continue to lead with purpose, innovation and a deep commitment to serving customers around the globe.”

    About Tokio Marine HCC
    Tokio Marine HCC is a member of the Tokio Marine Group, a premier global company founded in 1879 with a market capitalization of $74 billion as of March 31, 2025. Headquartered in Houston, Texas, Tokio Marine HCC is a leading specialty insurance group with offices in the United States, Mexico, the United Kingdom and Continental Europe. Tokio Marine HCC’s major domestic insurance companies have financial strength ratings of ‘A+’ (Strong) from S&P Global Ratings, ‘A++’ (Superior) from AM Best, and ‘AA-’ (Very Strong) from Fitch Ratings; its major international insurance companies have financial strength ratings of ‘A+’ (Strong) from S&P Global Ratings. Tokio Marine HCC is the marketing name used to describe the affiliated companies under the common ownership of HCC Insurance Holdings, Inc., a Delaware-incorporated insurance holding company. For more information about Tokio Marine HCC, please visit www.tokiomarinehcc.com.

    About WorldTrips
    WorldTrips, located in Carmel, Indiana, is a full-service organization offering a comprehensive portfolio of travel medical and trip protection insurance products designed to address the insurance needs of travelers worldwide. WorldTrips is a member of the Tokio Marine HCC group of companies. For more information about WorldTrips, please visit WorldTrips.com.

    In the State of California, operating as WorldTrips Insurance Services. California Non-Resident Producer License Number: 0G39705.

    Contact: Doug Busker, Vice President – Public Relations
      Tokio Marine HCC
      713-996-1192

    The MIL Network –

  • MIL-OSI: The world’s leading cloud mining brand: BJMining launches a new cloud mining guide

    Source: GlobeNewswire (MIL-OSI)

    London, UK, July 08, 2025 (GLOBE NEWSWIRE) — As the price of Bitcoin stabilizes above $108,000, the entire crypto market is showing a positive recovery trend. Data shows that global investors are gradually shifting from high-risk, high-volatility cryptocurrency speculation to a more sustainable, low-threshold long-term mining income model. As the world’s leading green cloud mining platform, BJMining is taking advantage of the opportunity to launch a new user guide to help ordinary users easily open a new era of passive income from digital assets.

    What is BJMining?

    Founded in 2015, BJMining is a global intelligent cloud mining platform headquartered in the UK. The platform is committed to transforming the traditional complex mining machine construction into a one-stop cloud service, and through AI scheduling system and green energy mines, it provides safe, convenient and high-yield mining solutions for more than 5 million users worldwide.

    BJMining CEO: “Turning mining into a daily income tool for people around the world”

    William Thomas, CEO of BJMining, said: “Cloud mining should no longer be exclusive to the technical elite. Our mission is to create a safe, green, barrier-free long-term income solution for users around the world. The launch of this new guide will further lower the threshold for user participation and help everyone enjoy the dividends of the digital economy.”

    Six core highlights: How BJMining redefines the “mining experience”

    • Register now to enjoy $15 cloud newcomer bonus, truly zero-cost trial mining:
      Users can get a $15 new member reward by registering. They can receive $0.6 in income every day without recharging, and easily experience the real mining process.
    • AI intelligently allocates the best-yield mining machine, no operation required:
      The AI ​​algorithm independently developed by the platform will automatically analyze the real-time currency price, difficulty, and popularity, and dynamically switch to mining assets with the best returns, covering BTC, DOGE, ETH, LTC and other currencies.
    • Global green energy layout to achieve 100% carbon neutrality:
      BJMining has deployed multiple solar- and wind-powered data centers in North America, Europe, Latin America, and the Middle East. All mining machines are powered by renewable energy, ensuring both environmental protection and high efficiency.
    • Diversified contracts can be freely configured to meet different user strategies:
      The platform contracts range from short-term contracts of 2 days to long-term contracts of 45 days, which can meet the diverse needs of miners from novices to experienced miners. Users can combine their positions at any time to optimize the mining income structure.
    • Powerful App management system, income withdrawals are instantly credited to your account:
      BJMining App is now available on both iOS and Android platforms, supporting real-time contract tracking, wallet binding and one-click withdrawal of earnings, with an average withdrawal time of less than 60 seconds.
    • High referral rewards:
      3% for direct referrals and 2% for indirect referrals, with no upper limit on earnings.

    Investor behavior changes: from cryptocurrency speculation to stable mining

    More and more long-term holders of XRP, SOL, ETH, etc. have begun to abandon high-volatility intraday operations and instead choose low-intervention, continuous-yield cloud mining platforms like BJMining as the core way to preserve and increase the value of their assets.

    User feedback shows that BJMining’s medium- and long-term contracts can bring stable returns of up to thousands of dollars per day, especially when the currency price fluctuates or goes sideways, showing strong risk resistance.

    Some of the hot-selling contracts are as follows:

    • WhatsMiner M50S+：Invest $100 for 2 days, total net income is $106;
    • WhatsMiner M60S++：Invest $600 for 7 days, total net income is $652.50;
    • Avalon Miner A1566：Invest $1200 for 15 days, total net income is $1434;
    • WhatsMiner M66S+：Invest $5800 for 30 days, total net income is $8410;
    • Antminer L7：Invest $12000 for 40 days, total net income is $20160;
    • Antminer S21e XP Hyd：Invest $27000 for 45 days, total net income is $48870;

    (All contracts are automatically scheduled by AI, settled daily, and can be flexibly withdrawn)

    Global layout upgraded again, future development blueprint exposed

    In order to serve more users, BJMining will launch the following strategic modules:

    • XRP chain-specific smart mining contracts and cross-chain mining machine adaptation technology
    • Green computing power NFT certification system, showing carbon neutrality footprint online
    • Multi-currency stable income pool, integrating DOGE, BTC, and XRP for joint mining
    • Web3 wallet one-click binding mechanism improves user on-chain asset management experience

    Conclusion:

    As a global green and compliant cloud mining brand, BJMining not only provides new users with a $15 new user bonus, but also opens a new path to financial freedom for everyone in the world. No equipment, no professional knowledge, no need to deal with the drastic fluctuations in the currency market, truly realizing “passive income in the cloud”.

    Register a BJMining account now, receive a $15 new member reward, and start your own mining journey!

    Official website address: https://bjmining.com
    Official email: info@bjmining.com

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    The MIL Network –

  • MIL-OSI: Topnotch Crypto Unveils Mobile App to Simplify Cloud Mining for Users Worldwide

    Source: GlobeNewswire (MIL-OSI)

    New York, July 08, 2025 (GLOBE NEWSWIRE) — Topnotch Crypto, a global innovator in the cloud mining sector, has officially launched its new mobile application, aimed at making cryptocurrency mining more accessible and user-friendly for everyday users. Now available on both iOS and Android platforms, the app enables individuals to participate in cloud mining directly from their smartphones—no technical expertise or hardware setup required.

    As the blockchain and crypto landscape continues to evolve, accessibility remains a key challenge for many interested in decentralized technologies. The Topnotch Crypto app seeks to lower the entry barrier by offering a streamlined interface, a variety of cloud mining contract options, and real-time tracking of mining activity, all from a mobile device.

    “We developed this app with a simple goal: to bring cloud mining within reach of a global user base,” said a spokesperson for Topnotch Crypto. “By combining intuitive design with powerful infrastructure, we’re enabling users to engage with blockchain technology more easily and sustainably.”

    The app integrates energy-efficient cloud mining operations supported by green energy solutions, reinforcing Topnotch Crypto’s commitment to environmental responsibility. The platform’s automated processes allow mining to operate around the clock, ensuring consistency and convenience for users.

    Features of the Topnotch Crypto App:

    • Intuitive Onboarding: Quick setup and registration for new users.
    • Flexible Contracts: Choose from short-term and long-term cloud mining options.
    • Real-Time Dashboard: Monitor mining activity and performance metrics on the go.
    • Sustainable Approach: Operations powered by renewable energy sources.

    Available Cloud Mining Contracts:

    • Introductory Trial Plan: A free option for first-time users to explore the platform.
    • 7-Day Access Plan: Ideal for short-term engagement.
    • 10-Day Plan: A balanced plan offering moderate duration.
    • 30-Day Plan: Designed for users with long-term mining goals.

    The Topnotch Crypto app is now available for download on iOS and Android. To learn more or to get started, visit: https://topnotchcrypto.com

    About Topnotch Crypto

    Topnotch Crypto is a leading provider of cloud mining services, dedicated to making digital asset technologies accessible worldwide. Through user-focused tools, sustainable infrastructure, and transparent operations, the company continues to expand its footprint in the evolving Web3 space.

    More details

    Click to download the mobile APP

    Official email: info@topnotchcrypto.com

    Disclaimer: The information provided in this press release does not constitute an investment solicitation, nor does it constitute investment advice, financial advice, or trading recommendations. Cryptocurrency mining and staking involve risks and the possibility of losing funds. It is strongly recommended that you perform due diligence before investing or trading in cryptocurrencies and securities, including consulting a professional financial advisor.

    The MIL Network –

  • MIL-OSI: Topnotch Crypto Unveils Mobile App to Simplify Cloud Mining for Users Worldwide

    Source: GlobeNewswire (MIL-OSI)

    New York, July 08, 2025 (GLOBE NEWSWIRE) — Topnotch Crypto, a global innovator in the cloud mining sector, has officially launched its new mobile application, aimed at making cryptocurrency mining more accessible and user-friendly for everyday users. Now available on both iOS and Android platforms, the app enables individuals to participate in cloud mining directly from their smartphones—no technical expertise or hardware setup required.

    As the blockchain and crypto landscape continues to evolve, accessibility remains a key challenge for many interested in decentralized technologies. The Topnotch Crypto app seeks to lower the entry barrier by offering a streamlined interface, a variety of cloud mining contract options, and real-time tracking of mining activity, all from a mobile device.

    “We developed this app with a simple goal: to bring cloud mining within reach of a global user base,” said a spokesperson for Topnotch Crypto. “By combining intuitive design with powerful infrastructure, we’re enabling users to engage with blockchain technology more easily and sustainably.”

    The app integrates energy-efficient cloud mining operations supported by green energy solutions, reinforcing Topnotch Crypto’s commitment to environmental responsibility. The platform’s automated processes allow mining to operate around the clock, ensuring consistency and convenience for users.

    Features of the Topnotch Crypto App:

    • Intuitive Onboarding: Quick setup and registration for new users.
    • Flexible Contracts: Choose from short-term and long-term cloud mining options.
    • Real-Time Dashboard: Monitor mining activity and performance metrics on the go.
    • Sustainable Approach: Operations powered by renewable energy sources.

    Available Cloud Mining Contracts:

    • Introductory Trial Plan: A free option for first-time users to explore the platform.
    • 7-Day Access Plan: Ideal for short-term engagement.
    • 10-Day Plan: A balanced plan offering moderate duration.
    • 30-Day Plan: Designed for users with long-term mining goals.

    The Topnotch Crypto app is now available for download on iOS and Android. To learn more or to get started, visit: https://topnotchcrypto.com

    About Topnotch Crypto

    Topnotch Crypto is a leading provider of cloud mining services, dedicated to making digital asset technologies accessible worldwide. Through user-focused tools, sustainable infrastructure, and transparent operations, the company continues to expand its footprint in the evolving Web3 space.

    More details

    Click to download the mobile APP

    Official email: info@topnotchcrypto.com

    Disclaimer: The information provided in this press release does not constitute an investment solicitation, nor does it constitute investment advice, financial advice, or trading recommendations. Cryptocurrency mining and staking involve risks and the possibility of losing funds. It is strongly recommended that you perform due diligence before investing or trading in cryptocurrencies and securities, including consulting a professional financial advisor.

    The MIL Network –

  • MIL-OSI: VNBTC Launches Free Cloud Mining Platform: Mine Bitcoin, Litecoin, and Dogecoin on Your Phone at Zero Cost

    Source: GlobeNewswire (MIL-OSI)

    LONDON, July 08, 2025 (GLOBE NEWSWIRE) — As Bitcoin trades above $109,000 and nears its all-time high, the VNBTC cloud mining platform offers a simple, zero-cost way for users to passively earn crypto via their mobile devices.

    “Our new crypto cloud mining strategies help users start earning passive income without any upfront cost,” a VNBTC spokesperson said. “With profitable mining plans, an advanced mobile app, and a free bonus on sign-up, anyone can join and benefit from the ongoing crypto boom without any barrier.”

    Platform’s Key Benefits Outlook

    • UK Registered & Compliant — Fully legal and transparent for your peace of mind.
    • Easy to Start — Just $79 to begin, no hardware or tech skills needed.
    • Mine Multiple Coins — BTC, ETH, LTC, and DOGE all in one place, switch anytime.
    • 100% Cloud-Based — Run remotely on VNBTC’s servers, just invest and track.
    • Global Network — 100+ data centers for reliable, nonstop uptime.
    • Eco-Friendly Mining — Powered by renewable energy to cut environmental impact.
    • Daily Passive Income — Get steady daily payouts, with some plans offering great returns.
    • Referral Bonuses — Earn rewards by inviting friends or sharing online, no extra cost.

    Follow these simple guidelines and start earning cryptocurrency passive income from today:

    1. Register with VNBTC and receive a $79 bonus to get started.
    2. Choose the plan that works best for you.
    3. Activate your plan and keep track of your earnings anytime with their app.
    4. Enjoy daily payouts—withdraw or reinvest whenever you want.

    Conclusion

    Comparing VNBTC to traditional mining methods, you can clearly see that the platform offers a better opportunity for everyday investors who want to begin crypto mining. It is a secure, modern cloud mining app that provides powerful tools and high-yield mining plans to everyday investors. Also, users get to benefit from bonuses, a rewarding referral, and bounty programs with minimal effort and zero cost.

    Media Contact:
    James Carter
    Marketing Specialist, VNBTC
    James.Carter@vnbtc.com

    Support Contact:
    support@vnbtc.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6081a32f-8775-4f23-98d4-3724997dab72

    The MIL Network –

  • MIL-OSI: VNBTC Launches Free Cloud Mining Platform: Mine Bitcoin, Litecoin, and Dogecoin on Your Phone at Zero Cost

    Source: GlobeNewswire (MIL-OSI)

    LONDON, July 08, 2025 (GLOBE NEWSWIRE) — As Bitcoin trades above $109,000 and nears its all-time high, the VNBTC cloud mining platform offers a simple, zero-cost way for users to passively earn crypto via their mobile devices.

    “Our new crypto cloud mining strategies help users start earning passive income without any upfront cost,” a VNBTC spokesperson said. “With profitable mining plans, an advanced mobile app, and a free bonus on sign-up, anyone can join and benefit from the ongoing crypto boom without any barrier.”

    Platform’s Key Benefits Outlook

    • UK Registered & Compliant — Fully legal and transparent for your peace of mind.
    • Easy to Start — Just $79 to begin, no hardware or tech skills needed.
    • Mine Multiple Coins — BTC, ETH, LTC, and DOGE all in one place, switch anytime.
    • 100% Cloud-Based — Run remotely on VNBTC’s servers, just invest and track.
    • Global Network — 100+ data centers for reliable, nonstop uptime.
    • Eco-Friendly Mining — Powered by renewable energy to cut environmental impact.
    • Daily Passive Income — Get steady daily payouts, with some plans offering great returns.
    • Referral Bonuses — Earn rewards by inviting friends or sharing online, no extra cost.

    Follow these simple guidelines and start earning cryptocurrency passive income from today:

    1. Register with VNBTC and receive a $79 bonus to get started.
    2. Choose the plan that works best for you.
    3. Activate your plan and keep track of your earnings anytime with their app.
    4. Enjoy daily payouts—withdraw or reinvest whenever you want.

    Conclusion

    Comparing VNBTC to traditional mining methods, you can clearly see that the platform offers a better opportunity for everyday investors who want to begin crypto mining. It is a secure, modern cloud mining app that provides powerful tools and high-yield mining plans to everyday investors. Also, users get to benefit from bonuses, a rewarding referral, and bounty programs with minimal effort and zero cost.

    Media Contact:
    James Carter
    Marketing Specialist, VNBTC
    James.Carter@vnbtc.com

    Support Contact:
    support@vnbtc.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6081a32f-8775-4f23-98d4-3724997dab72

    The MIL Network –

  • MIL-OSI: XAVIER DEROT APPOINTED DEPUTY CHIEF EXECUTIVE OFFICER OF MOBILIZE FINANCIAL SERVICES

    Source: GlobeNewswire (MIL-OSI)

    July 3rd, 2025  

    PRESS RELEASE

    XAVIER DEROT APPOINTED DEPUTY CHIEF EXECUTIVE OFFICER OF MOBILIZE FINANCIAL SERVICES

    Martin Thomas, Chief Executive Officer of Mobilize Financial Services, has announced the appointment of Xavier Derot as Deputy CEO, effective July 1, 2025. This appointment is subject to the approval of the European Central Bank. 

    Xavier Derot, currently VP, Sales and Operations and a member of the Executive Committee of Mobilize Financial Services since September 1, 2024, will take up the role of Deputy CEO alongside Vincent Gellé, starting July 1, 2025. 

    This second appointment aims to strengthen the bank’s governance. 

    About Xavier Derot 

    Xavier Derot, 52, began his career at RCI Banque in 2000 as Head of International Development. 
    A graduate of the Grenoble Graduate School of Business in 1994, he held various positions within RCI Banque, both internationally in three different countries and in corporate functions. 
    Among these roles, he notably managed the bank’s relationship with Nissan from 2006 to 2010 and served as Regional Operations Director for RCI Banque’s G10 and Euromed subsidiaries. 
    Abroad, Xavier served as Managing Director of the German subsidiary and then of RN Bank Russia—the joint venture between RCI Bank-Nissan and UniCredit in Russia—between 2013 and 2022. Since October 2022, Xavier has held the position of International Director of Mobilize Financial Services, overseeing operations in 12 countries within the Group. 
    Since September 1, 2024, he has served as VP, Sales and Operations on the Executive Committee of Mobilize Financial Services. 
    Xavier is married and has two children. 

    Contact

    About Mobilize Financial Services    
    Attentive to the needs of all its customers, Mobilize Financial Services, a subsidiary of Renault Group, creates innovative financial services to build sustainable mobility for all. Mobilize Financial Services, which began operations over 100 years ago, is the commercial brand of RCI Banque SA, a French bank specializing in automotive financing and services for customers and networks of Renault Group, and also for the brands Nissan and Mitsubishi in several countries. 
    With operations in 35 countries and over 4,000 employees, Mobilize Financial Services financed more than 1,2 million contracts (new and used vehicles) in 2023 and sold 3,7 million service contracts. At the end of December 2024, average earning assets stood at 61 billion euros of financing and pre-tax earnings at 1 194 million euros.
    Since 2012, the Group has deployed a deposit-taking business in several countries. At the end of December 2024, net deposits amounted to 30,5 billion euros, or 50 % of the company’s net assets.    
    To find out more about Mobilize Financial Services: www.mobilize-fs.com/   

    Attachment

    The MIL Network –

  • MIL-OSI: Solomon Partners Hires Jonathan Hemmert as a Partner to Build a Dedicated Professional Services Group

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) — Solomon Partners, a leading financial advisory firm and independent affiliate of Natixis, today announced that Jonathan Hemmert joined the firm as a Partner in its newly formed Professional Services Group. With over 20 years of experience, Mr. Hemmert brings deep expertise to Solomon. In this role, he will serve clients within the Professional Services space, focusing on Human Capital businesses, including specialized broker-dealers and consulting firms.

    Previously, Mr. Hemmert was a Managing Director at Keefe, Bruyette & Woods (KBW), where he led the firm’s efforts across the broker-dealer and specialty advisory space. His notable transaction experience includes the sale of Battea-Class Action Services to SS&C Technologies, Aviditi Advisors to Piper Sandler, Triago to Houlihan Lokey, CRC-IB by CohnReznick to Canaccord Genuity, DBO Partners to Piper Sandler, Capstone Partners to Mizuho, and DH Capital to Citizens Financial. Mr. Hemmert graduated summa cum laude with a BA from Bucknell University.

    “Jonathan has an exceptional track record of advising clients across the Professional Services landscape,” said Marc Cooper, CEO of Solomon Partners. “His deep industry expertise and commitment to clients make him a perfect addition to our growing team.”

    “I look forward to joining Solomon’s growth-oriented platform. The firm’s entrepreneurial and client-centric culture will resonate with the core client base across the Professional Services and Human Capital sectors,” Mr. Hemmert commented. “The professional services landscape is evolving fast. The influx of institutional capital is going to accelerate and broaden the scope of M&A activity, and we will continue to be at the forefront of this marketplace.”

    About Solomon Partners

    Solomon Partners is a leading investment bank – one of the first independent firms in the industry. We maximize shareholder value for our clients through our unmatched expertise and experience. We advise on mergers & acquisitions, restructurings and capital solutions across a range of sectors including Business Services; Consumer Retail; Distribution; Financial Institutions; Financial Sponsors; Fintech; Grocery, Pharmacy & Restaurants; Healthcare; Industrials; Infrastructure, Power & Renewables; Media & Entertainment; Professional Services; and Technology. Solomon Partners is an independently operated affiliate of Natixis, part of Groupe BPCE. For further information, visit solomonpartners.com.

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0b7fcbf4-e248-4cd0-8a69-d4df798c7ffc

    The MIL Network –

  • MIL-OSI: Bell Wealth Partners Launches with Support of LPL Strategic Wealth Services

    Source: GlobeNewswire (MIL-OSI)

    SAN DIEGO, July 08, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that father and son financial advisors Robert Bell, II, AIF®, and Keegan Bell, AIF®, AAMS®, have launched a new independent practice, Bell Wealth Partners, through affiliation with LPL Financial’s supported independence model, LPL Strategic Wealth Services. The team reported serving approximately $450 million in advisory, brokerage and retirement plan assets* and joins LPL from Raymond James.

    Headquartered in Fairbanks, Alaska with an additional office in Medford, Ore., the ensemble practice has developed a strong reputation over the years for providing holistic experiences and personalized services to address each aspect of a client’s financial life. The Bells are managing partners of the firm and are joined by fellow advisor Tom Cook and client associates Renee Schoettle, Margarita Duran-Espino, Jamie Walker and Kirsten Bell, Robert’s wife.

    “We are all deeply invested in helping our clients work toward their financial goals,” Robert said. “We take the time to get to know each client on a personal level to better understand their financial aspirations, and we work with their accountants and attorneys to create a customized plan that is right for them. It’s our goal to help clients have happy, fulfilled lives, and we consider it our privilege and responsibility to help them with that.”

    Why they made the move to LPL Financial

    The transition to LPL Financial is underpinned by the team’s aspiration to augment client experiences and cater to the next generation of wealth.

    “We’re moving to LPL so we can add more value to the client experience as we seek new ways to go above and beyond,” Keegan said. “We want to be a one-stop shop—a center to help with a clients’ entire financial situation. This move allows us to really increase that value add and better take care of them, not just for them but for the next generation of wealth and the transfer to their beneficiaries.”

    The team was drawn to LPL’s comprehensive supported independence solution, LPL Strategic Wealth Services (SW), which combines the freedom and flexibility of entrepreneurship with hands-on business services and support to help practices thrive, both operationally and strategically. In addition to having access to LPL’s innovative wealth management platform and sophisticated resources, SW advisors benefit from a truly integrated service that includes simplified pricing, technology and dedicated support to launch their practice. Then, after the transition is complete, SW teams receive ongoing operations support managed by their team of experienced professionals including a business strategist, marketing partner, CFO and administrative assistant. Advisors have one point of contact, a dedicated team and priority access to advocacy and project management for complex business issues, ultimately allowing them to stay focused on the enduring needs of their clients and the culture and evolution of their practice.

    “Strategic Wealth Services was truly a differentiating factor in our decision to move,” Robert said. “We are joining a very niche group at LPL, which allows us to collaborate with others in the model and access a team of specialists, including high-net-worth and trust consultants. This move enables us to add an extra layer of planning and ensure we’re not just taking care of clients now, but their beneficiaries as well.”

    Scott Posner, LPL Managing Director, Business Development, said, “We welcome Robert, Keegan, Tom, Renee, Margarita, Jamie and Kirsten to the LPL community and congratulate them on going independent with LPL Strategic Wealth. Just as the Bell Wealth Partners team is committed to helping their clients work toward their fiscal goals, LPL provides advisors with innovative technology and sophisticated capabilities to help them provide an elevated client experience. We look forward to supporting Bell Wealth Partners for years to come.”

    Related

    Advisors, learn how LPL Financial can help take your business to the next level.

    About LPL Financial

    LPL Financial Holdings Inc. (Nasdaq: LPLA) is among the fastest growing wealth management firms in the U.S. As a leader in the financial advisor-mediated marketplace, LPL supports nearly 29,000 financial advisors and the wealth management practices of approximately 1,200 financial institutions, servicing and custodying approximately $1.8 trillion in brokerage and advisory assets on behalf of approximately 7 million Americans. The firm provides a wide range of advisor affiliation models, investment solutions, fintech tools and practice management services, ensuring that advisors and institutions have the flexibility to choose the business model, services, and technology resources they need to run thriving businesses. For further information about LPL, please visit www.lpl.com.

    Securities and advisory services offered through LPL Financial LLC (“LPL Financial”), a registered investment advisor and broker-dealer, member FINRA/SIPC.

    Throughout this communication, the terms “financial advisors” and “advisors” are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial. Bell Wealth Partners and LPL are separate entities.

    We routinely disclose information that may be important to shareholders in the “Investor Relations” or “Press Releases” section of our website.

    *Value approximated based on asset and holding details provided to LPL from end of year, 2024.

    Media Contact: 
    Media.relations@LPLFinancial.com 

    Tracking #760446

    The MIL Network –

  • MIL-OSI: Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

    Source: GlobeNewswire (MIL-OSI)

    PALM BEACH, Fla., July 08, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions of dollars in the coming years. Several factors are driving this expansion, including rising cancer incidence, advancements in therapies like precision medicine and immunotherapy, and increased investment in research and development. A report from Grand View Research said that the global breakthrough therapy designation market size is projected to grow at a CAGR of 14.2% through 2030. It is a process designed to escalate the development and assessment of sanctioning of drugs & biologics that are proposed for treating severe diseases, whereas primary clinical evidence notifies that the drug determines considerable enhancement over existing therapy on a clinically significant endpoint. Furthermore, the BT (Breakthrough) designation lets pharma companies hasten the developmental process by offering additional support and assistance from the FDA and making medications available to the public faster. The report continued: “Apart from breakthrough designation therapy, there are some important tools, all of which have been in place for many years, such as fast-track designation, accelerated approval, and priority review. All of these are inclined toward approving drugs used to treat serious disorders. Although these processes can reduce a drug’s time to market, standard clinical testing is required for the development process, which usually involves three phases of large-scale and controlled trials.” Active oncology biotech and pharma companies in the markets this week include Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), Mustang Bio, Inc. (NASDAQ: MBIO), Verastem Oncology (NASDAQ: VSTM), Cardiff Oncology, Inc. (NASDAQ: CRDF), AstraZeneca PLC (NASDAQ: AZN).

    Grand View Research continued: “The increasing prevalence of life-threatening conditions and the necessity for the rapid development of pipeline drugs are also some factors that propel the breakthrough therapy drug market. This is primarily driven by the significant unmet need for effective treatments for severe conditions currently available. Manufacturing companies are particularly attentive to drugs designated as breakthrough therapies due to the accelerated market access and higher returns on investment. Breakthrough therapy drugs often undergo less extensive clinical trials, which is a direct consequence of their market designation. The FDA’s enhanced support for small-scale industries in research and development, including increased funding and expedited drug approval processes, is further stimulating the market for breakthrough therapy drugs. Collectively, these elements are pushing the breakthrough therapy drug market forward. Further, innovative gene and cell therapies are offering new treatment decisions for previously untreatable illnesses, mainly drifting to more breakthrough therapy designations. Moreover, the regulatory support agencies are streamlining processes and offering assistance for breakthrough therapies to speed up their development and sanction. Another aspect leading the breakthrough therapy designations is the cross-sector collaborations between academic institutions, pharmaceutical companies, and research institutes that are lifting the upgradation and the advancement of new breakthrough therapies completely.”

    Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC) Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies

    • Comparison with multiple landmark first-line metastatic pancreatic ductal adenocarcinoma studies substantiates strong two-year survival benefit of 21.9% vs. 9.2% historical benchmark
    • Consistent survival benefit compared to standard-of-care chemotherapy in randomized studies in the large HR+/HER2- metastatic breast cancer indication
    • Data from over 1,100 patients across tumor types reveals a favorable, well-understood safety profile

    — Oncolytics Biotech ® Inc. ($ONCY $ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced a strategic update highlighting its compelling clinical data from two tumor types and outlining a sharpened focus on advancing pelareorep, the Company’s intravenously delivered oncolytic virus immunotherapy, into registration-enabling studies.

    “We are no longer in the business of funding proof-of-concept studies,” said Jared Kelly, Chief Executive Officer of Oncolytics. “We have meaningful clinical data in hand—not just signals. The survival benefit across multiple tumor types demands a focused approach to take pelareorep directly into registration-enabling trials. We will use our fast-track status to find the most efficient regulatory path forward this summer to advance our platform in a product technology.”

    Results from two completed first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) trials demonstrate a strong and consistent efficacy signal showing extremely rare 2-year overall survival rates of 21.9% vs. 9.2% based on pooled data from over 100 patients across two studies evaluating pelareorep combined with a chemotherapy backbone. In addition, a best-in-class 62% objective response rate (ORR) was observed in a single-arm study of pelareorep in combination with a chemotherapy backbone and a checkpoint inhibitor in 13 evaluable patients. These results collectively represent promising efficacy for a therapeutic regimen that includes an immunotherapy in this difficult-to-treat cancer. Currently, there are no approved immunotherapies for first-line treatment of mPDAC…

    …Pelareorep’s clinical activity in HR+/HER2- metastatic breast cancer – a large indication with continued significant unmet medical need and no currently approved immunotherapies – has been demonstrated in two randomized phase 2 studies, both of which showed a median overall survival (mOS) benefit of greater than 10 months compared to standard-of-care chemotherapy (IND.213 mOS: 21.0 vs. 10.8 months; BRACELET-1 mOS: not statistically reached; conservative estimate = 32.1 months vs. 18.2 months). In the randomized, controlled BRACELET-1 study, pelareorep combined with paclitaxel yielded a 12.1-month median progression-free survival (PFS) compared to 6.4 months in the paclitaxel alone control arm.

    “Pelareorep represents a tipping point for immunotherapy in cold tumors,” said Dr. Thomas Heineman, Chief Medical Officer of Oncolytics. “It is delivering consistent immunologic and clinical responses in multiple tumor types. Most impressively, pelareorep activates the immune system to produce clinical benefits in cancers that are typically unresponsive to immunotherapies like mPDAC and unresectable HR+/HER2- breast cancer, creating new oncology entry points for immune-based combination therapies.” CONTINUED… Read these full press releases and more news for ONCY at: https://www.financialnewsmedia.com/news-oncy/

    Other recent oncology developments in the biotech industry of note include:

    Mustang Bio, Inc. (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, recently announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to Mustang for MB-101 (IL13Ra2-targeted CAR T-cells) for the treatment of recurrent diffuse and anaplastic astrocytoma (astrocytomas) and glioblastoma (GBM).

    The FDA grants Orphan Drug Designation to drugs and biologics that are intended for safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Orphan Drug Designation provides certain incentives, such as tax credits toward the cost of clinical trials upon approval and prescription drug user fee waivers. If a product receives Orphan Drug Status from the FDA, that product is entitled to seven years of market exclusivity for the disease in which it has Orphan Drug designation, which is independent from intellectual property protection.

    Verastem Oncology (NASDAQ: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, recently announced that updated results from the Phase 1/2 FRAME study conducted by The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were published online in Nature Medicine. The full manuscript, titled “Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial,” was the first-in-human study to evaluate the safety, tolerability, and efficacy of avutometinib in combination with defactinib in patients with low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), and other solid tumor types.

    “The FRAME study was the early foundation for the recent FDA approval of avutometinib plus defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer and we are pleased to see that the mature data set continues to show the safety and tolerability of this combination therapy,” said Dan Paterson, president and chief executive officer of Verastem Oncology. “This supports our ongoing commitment to advancing our research into the combination for use in other solid tumors, including RAMP 205 in first-line metastatic pancreatic cancer.”

    Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently announced the company has appointed Roger Sidhu, MD, as Chief Medical Officer. Dr. Sidhu is a veteran executive and clinician with over 20 years of experience and a strong track record of success in oncology research, development, and regulatory strategy. Dr. Sidhu succeeds Dr. Fairooz Kabbinavar who will remain with the company in an advisory role. The company also announced it will share additional clinical data from its lead program in RAS-mutated mCRC on July 29, 2025.

    “We are pleased to welcome Dr. Sidhu to lead the clinical program for onvansertib through the next phase of development. Dr. Sidhu is a respected clinician and seasoned executive with a proven track record of advancing innovative therapies through late-stage clinical development across multiple therapeutic areas including in first-line mCRC. As we move forward, we thank Dr. Kabbinavar for his leadership in progressing onvansertib’s clinical development across multiple tumor types,” said Mark Erlander, Chief Executive Officer of Cardiff Oncology. “In addition to today’s medical leadership transition, we are announcing our plan to share an update of clinical data from the ongoing CRDF-004 trial on July 29, at which point we expect to release a substantive dataset.”

    AstraZeneca PLC (NASDAQ: AZN)‘s Imfinzi (durvalumab) has been approved in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).

    The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use and is based on results from the NIAGARA Phase III trial, which were published in The New England Journal of Medicine.

    In a planned interim analysis, the Imfinzi-based perioperative regimen demonstrated a statistically significant 32% reduction in the risk of disease progression, recurrence, not undergoing surgery, or death versus neoadjuvant chemotherapy with radical cystectomy alone (based on event-free survival [EFS] hazard ratio [HR] of 0.68; 95% confidence interval [CI] 0.56-0.82; p<0.0001). Estimated median EFS was not yet reached for the Imfinzi arm versus 46.1 months for the comparator arm. An estimated 67.8% of patients treated with the regimen were event free at two years compared to 59.8% in the comparator arm.

    About FN Media Group:

    At FN Media Group, via our top-rated online news portal at www.financialnewsmedia.com, we are one of the very few select firms providing top tier one syndicated news distribution, targeted ticker tag press releases and stock market news coverage for today’s emerging companies. #pressreleases #tickertagpressreleases

    Follow us on Facebook to receive emerging news updates: https://www.facebook.com/financialnewsmedia

    Follow us on Twitter for real time Breaking News: https://twitter.com/FNMgroup

    Follow us on Linkedin: https://www.linkedin.com/in/financialnewsmedia/

    DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech® Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

    This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

    Contact Information:

    Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757 

    SOURCE: FN Media Group

    The MIL Network –

  • MIL-OSI: Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

    Source: GlobeNewswire (MIL-OSI)

    PALM BEACH, Fla., July 08, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions of dollars in the coming years. Several factors are driving this expansion, including rising cancer incidence, advancements in therapies like precision medicine and immunotherapy, and increased investment in research and development. A report from Grand View Research said that the global breakthrough therapy designation market size is projected to grow at a CAGR of 14.2% through 2030. It is a process designed to escalate the development and assessment of sanctioning of drugs & biologics that are proposed for treating severe diseases, whereas primary clinical evidence notifies that the drug determines considerable enhancement over existing therapy on a clinically significant endpoint. Furthermore, the BT (Breakthrough) designation lets pharma companies hasten the developmental process by offering additional support and assistance from the FDA and making medications available to the public faster. The report continued: “Apart from breakthrough designation therapy, there are some important tools, all of which have been in place for many years, such as fast-track designation, accelerated approval, and priority review. All of these are inclined toward approving drugs used to treat serious disorders. Although these processes can reduce a drug’s time to market, standard clinical testing is required for the development process, which usually involves three phases of large-scale and controlled trials.” Active oncology biotech and pharma companies in the markets this week include Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), Mustang Bio, Inc. (NASDAQ: MBIO), Verastem Oncology (NASDAQ: VSTM), Cardiff Oncology, Inc. (NASDAQ: CRDF), AstraZeneca PLC (NASDAQ: AZN).

    Grand View Research continued: “The increasing prevalence of life-threatening conditions and the necessity for the rapid development of pipeline drugs are also some factors that propel the breakthrough therapy drug market. This is primarily driven by the significant unmet need for effective treatments for severe conditions currently available. Manufacturing companies are particularly attentive to drugs designated as breakthrough therapies due to the accelerated market access and higher returns on investment. Breakthrough therapy drugs often undergo less extensive clinical trials, which is a direct consequence of their market designation. The FDA’s enhanced support for small-scale industries in research and development, including increased funding and expedited drug approval processes, is further stimulating the market for breakthrough therapy drugs. Collectively, these elements are pushing the breakthrough therapy drug market forward. Further, innovative gene and cell therapies are offering new treatment decisions for previously untreatable illnesses, mainly drifting to more breakthrough therapy designations. Moreover, the regulatory support agencies are streamlining processes and offering assistance for breakthrough therapies to speed up their development and sanction. Another aspect leading the breakthrough therapy designations is the cross-sector collaborations between academic institutions, pharmaceutical companies, and research institutes that are lifting the upgradation and the advancement of new breakthrough therapies completely.”

    Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC) Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies

    • Comparison with multiple landmark first-line metastatic pancreatic ductal adenocarcinoma studies substantiates strong two-year survival benefit of 21.9% vs. 9.2% historical benchmark
    • Consistent survival benefit compared to standard-of-care chemotherapy in randomized studies in the large HR+/HER2- metastatic breast cancer indication
    • Data from over 1,100 patients across tumor types reveals a favorable, well-understood safety profile

    — Oncolytics Biotech ® Inc. ($ONCY $ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced a strategic update highlighting its compelling clinical data from two tumor types and outlining a sharpened focus on advancing pelareorep, the Company’s intravenously delivered oncolytic virus immunotherapy, into registration-enabling studies.

    “We are no longer in the business of funding proof-of-concept studies,” said Jared Kelly, Chief Executive Officer of Oncolytics. “We have meaningful clinical data in hand—not just signals. The survival benefit across multiple tumor types demands a focused approach to take pelareorep directly into registration-enabling trials. We will use our fast-track status to find the most efficient regulatory path forward this summer to advance our platform in a product technology.”

    Results from two completed first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) trials demonstrate a strong and consistent efficacy signal showing extremely rare 2-year overall survival rates of 21.9% vs. 9.2% based on pooled data from over 100 patients across two studies evaluating pelareorep combined with a chemotherapy backbone. In addition, a best-in-class 62% objective response rate (ORR) was observed in a single-arm study of pelareorep in combination with a chemotherapy backbone and a checkpoint inhibitor in 13 evaluable patients. These results collectively represent promising efficacy for a therapeutic regimen that includes an immunotherapy in this difficult-to-treat cancer. Currently, there are no approved immunotherapies for first-line treatment of mPDAC…

    …Pelareorep’s clinical activity in HR+/HER2- metastatic breast cancer – a large indication with continued significant unmet medical need and no currently approved immunotherapies – has been demonstrated in two randomized phase 2 studies, both of which showed a median overall survival (mOS) benefit of greater than 10 months compared to standard-of-care chemotherapy (IND.213 mOS: 21.0 vs. 10.8 months; BRACELET-1 mOS: not statistically reached; conservative estimate = 32.1 months vs. 18.2 months). In the randomized, controlled BRACELET-1 study, pelareorep combined with paclitaxel yielded a 12.1-month median progression-free survival (PFS) compared to 6.4 months in the paclitaxel alone control arm.

    “Pelareorep represents a tipping point for immunotherapy in cold tumors,” said Dr. Thomas Heineman, Chief Medical Officer of Oncolytics. “It is delivering consistent immunologic and clinical responses in multiple tumor types. Most impressively, pelareorep activates the immune system to produce clinical benefits in cancers that are typically unresponsive to immunotherapies like mPDAC and unresectable HR+/HER2- breast cancer, creating new oncology entry points for immune-based combination therapies.” CONTINUED… Read these full press releases and more news for ONCY at: https://www.financialnewsmedia.com/news-oncy/

    Other recent oncology developments in the biotech industry of note include:

    Mustang Bio, Inc. (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, recently announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to Mustang for MB-101 (IL13Ra2-targeted CAR T-cells) for the treatment of recurrent diffuse and anaplastic astrocytoma (astrocytomas) and glioblastoma (GBM).

    The FDA grants Orphan Drug Designation to drugs and biologics that are intended for safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Orphan Drug Designation provides certain incentives, such as tax credits toward the cost of clinical trials upon approval and prescription drug user fee waivers. If a product receives Orphan Drug Status from the FDA, that product is entitled to seven years of market exclusivity for the disease in which it has Orphan Drug designation, which is independent from intellectual property protection.

    Verastem Oncology (NASDAQ: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, recently announced that updated results from the Phase 1/2 FRAME study conducted by The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were published online in Nature Medicine. The full manuscript, titled “Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial,” was the first-in-human study to evaluate the safety, tolerability, and efficacy of avutometinib in combination with defactinib in patients with low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), and other solid tumor types.

    “The FRAME study was the early foundation for the recent FDA approval of avutometinib plus defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer and we are pleased to see that the mature data set continues to show the safety and tolerability of this combination therapy,” said Dan Paterson, president and chief executive officer of Verastem Oncology. “This supports our ongoing commitment to advancing our research into the combination for use in other solid tumors, including RAMP 205 in first-line metastatic pancreatic cancer.”

    Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently announced the company has appointed Roger Sidhu, MD, as Chief Medical Officer. Dr. Sidhu is a veteran executive and clinician with over 20 years of experience and a strong track record of success in oncology research, development, and regulatory strategy. Dr. Sidhu succeeds Dr. Fairooz Kabbinavar who will remain with the company in an advisory role. The company also announced it will share additional clinical data from its lead program in RAS-mutated mCRC on July 29, 2025.

    “We are pleased to welcome Dr. Sidhu to lead the clinical program for onvansertib through the next phase of development. Dr. Sidhu is a respected clinician and seasoned executive with a proven track record of advancing innovative therapies through late-stage clinical development across multiple therapeutic areas including in first-line mCRC. As we move forward, we thank Dr. Kabbinavar for his leadership in progressing onvansertib’s clinical development across multiple tumor types,” said Mark Erlander, Chief Executive Officer of Cardiff Oncology. “In addition to today’s medical leadership transition, we are announcing our plan to share an update of clinical data from the ongoing CRDF-004 trial on July 29, at which point we expect to release a substantive dataset.”

    AstraZeneca PLC (NASDAQ: AZN)‘s Imfinzi (durvalumab) has been approved in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).

    The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use and is based on results from the NIAGARA Phase III trial, which were published in The New England Journal of Medicine.

    In a planned interim analysis, the Imfinzi-based perioperative regimen demonstrated a statistically significant 32% reduction in the risk of disease progression, recurrence, not undergoing surgery, or death versus neoadjuvant chemotherapy with radical cystectomy alone (based on event-free survival [EFS] hazard ratio [HR] of 0.68; 95% confidence interval [CI] 0.56-0.82; p<0.0001). Estimated median EFS was not yet reached for the Imfinzi arm versus 46.1 months for the comparator arm. An estimated 67.8% of patients treated with the regimen were event free at two years compared to 59.8% in the comparator arm.

    About FN Media Group:

    At FN Media Group, via our top-rated online news portal at www.financialnewsmedia.com, we are one of the very few select firms providing top tier one syndicated news distribution, targeted ticker tag press releases and stock market news coverage for today’s emerging companies. #pressreleases #tickertagpressreleases

    Follow us on Facebook to receive emerging news updates: https://www.facebook.com/financialnewsmedia

    Follow us on Twitter for real time Breaking News: https://twitter.com/FNMgroup

    Follow us on Linkedin: https://www.linkedin.com/in/financialnewsmedia/

    DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech® Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

    This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

    Contact Information:

    Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757 

    SOURCE: FN Media Group

    The MIL Network –

  • MIL-OSI: Primech A&P, a Subsidiary of Primech Holdings, Secures Major Contract Extension Worth Over $8.3 Million

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, July 08, 2025 (GLOBE NEWSWIRE) — Primech A & P, a subsidiary of Primech Holdings Limited (the “Company”) (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, today announced a 2-year contract extension valued at S$10,650,000 (US$8.3 million) providing comprehensive cleaning services at a renowned institution in Singapore.

    This contract renewal, a significant revenue contribution for Primech Holdings’ award-winning facility services subsidiary, reinforces Primech A & P’s competitive positioning in Singapore’s institutional cleaning market. Primech A & P’s proven track record of delivering reliable, high-touch facilities services enabled the Company to retain major institutional clients and generate predictable, recurring revenue streams.

    Ken Chang, Head of Operations at Primech A & P, stated, “This S$10.65 million contract extension validates our strategic focus on high-value institutional partnerships and demonstrates the strength of our service delivery model. The client’s decision to renew for an additional two years provides us with strong revenue visibility and reflects our ability to exceed performance expectations consistently. Primech A & P is a trusted partner in Singapore’s premium facility services market, and contract wins such as this support our continued growth trajectory.”

    About Primech Holdings Limited
     
    Headquartered in Singapore, Primech Holdings Limited is a leading provider of comprehensive technology-driven facilities services, predominantly serving both public and private sectors throughout Singapore. Primech Holdings offers an extensive range of services tailored to meet the complex demands of its diverse clientele. Services include advanced general facility maintenance services, specialized cleaning solutions such as marble polishing and facade cleaning, meticulous stewarding services, and targeted cleaning services for offices and homes. Known for its commitment to sustainability and cutting-edge technology, Primech Holdings integrates eco-friendly practices and smart technology solutions to enhance operational efficiency and client satisfaction. This strategic approach positions Primech Holdings as a leader in the industry and a proactive contributor to advancing industry standards and practices in Singapore and beyond. For more information, visit www.primechholdings.com.    

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements, including, for example, statements about completing the acquisition, anticipated revenues, growth, and expansion. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements are also based on assumptions regarding the Company’s present and future business strategies and the environment in which the Company will operate in the future. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

    Company Contact:
     Email: ir@primech.com.sg

    Investor Relations Contact:        
    Matthew Abenante, IRC
    President
    Strategic Investor Relations, LLC
    Tel: 347-947-2093
    Email: matthew@strategic-ir.com

    The MIL Network –

  • MIL-OSI: Primech A&P, a Subsidiary of Primech Holdings, Secures Major Contract Extension Worth Over $8.3 Million

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, July 08, 2025 (GLOBE NEWSWIRE) — Primech A & P, a subsidiary of Primech Holdings Limited (the “Company”) (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, today announced a 2-year contract extension valued at S$10,650,000 (US$8.3 million) providing comprehensive cleaning services at a renowned institution in Singapore.

    This contract renewal, a significant revenue contribution for Primech Holdings’ award-winning facility services subsidiary, reinforces Primech A & P’s competitive positioning in Singapore’s institutional cleaning market. Primech A & P’s proven track record of delivering reliable, high-touch facilities services enabled the Company to retain major institutional clients and generate predictable, recurring revenue streams.

    Ken Chang, Head of Operations at Primech A & P, stated, “This S$10.65 million contract extension validates our strategic focus on high-value institutional partnerships and demonstrates the strength of our service delivery model. The client’s decision to renew for an additional two years provides us with strong revenue visibility and reflects our ability to exceed performance expectations consistently. Primech A & P is a trusted partner in Singapore’s premium facility services market, and contract wins such as this support our continued growth trajectory.”

    About Primech Holdings Limited
     
    Headquartered in Singapore, Primech Holdings Limited is a leading provider of comprehensive technology-driven facilities services, predominantly serving both public and private sectors throughout Singapore. Primech Holdings offers an extensive range of services tailored to meet the complex demands of its diverse clientele. Services include advanced general facility maintenance services, specialized cleaning solutions such as marble polishing and facade cleaning, meticulous stewarding services, and targeted cleaning services for offices and homes. Known for its commitment to sustainability and cutting-edge technology, Primech Holdings integrates eco-friendly practices and smart technology solutions to enhance operational efficiency and client satisfaction. This strategic approach positions Primech Holdings as a leader in the industry and a proactive contributor to advancing industry standards and practices in Singapore and beyond. For more information, visit www.primechholdings.com.    

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements, including, for example, statements about completing the acquisition, anticipated revenues, growth, and expansion. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements are also based on assumptions regarding the Company’s present and future business strategies and the environment in which the Company will operate in the future. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

    Company Contact:
     Email: ir@primech.com.sg

    Investor Relations Contact:        
    Matthew Abenante, IRC
    President
    Strategic Investor Relations, LLC
    Tel: 347-947-2093
    Email: matthew@strategic-ir.com

    The MIL Network –

  • MIL-OSI: Primech A&P, a Subsidiary of Primech Holdings, Secures Major Contract Extension Worth Over $8.3 Million

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, July 08, 2025 (GLOBE NEWSWIRE) — Primech A & P, a subsidiary of Primech Holdings Limited (the “Company”) (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, today announced a 2-year contract extension valued at S$10,650,000 (US$8.3 million) providing comprehensive cleaning services at a renowned institution in Singapore.

    This contract renewal, a significant revenue contribution for Primech Holdings’ award-winning facility services subsidiary, reinforces Primech A & P’s competitive positioning in Singapore’s institutional cleaning market. Primech A & P’s proven track record of delivering reliable, high-touch facilities services enabled the Company to retain major institutional clients and generate predictable, recurring revenue streams.

    Ken Chang, Head of Operations at Primech A & P, stated, “This S$10.65 million contract extension validates our strategic focus on high-value institutional partnerships and demonstrates the strength of our service delivery model. The client’s decision to renew for an additional two years provides us with strong revenue visibility and reflects our ability to exceed performance expectations consistently. Primech A & P is a trusted partner in Singapore’s premium facility services market, and contract wins such as this support our continued growth trajectory.”

    About Primech Holdings Limited
     
    Headquartered in Singapore, Primech Holdings Limited is a leading provider of comprehensive technology-driven facilities services, predominantly serving both public and private sectors throughout Singapore. Primech Holdings offers an extensive range of services tailored to meet the complex demands of its diverse clientele. Services include advanced general facility maintenance services, specialized cleaning solutions such as marble polishing and facade cleaning, meticulous stewarding services, and targeted cleaning services for offices and homes. Known for its commitment to sustainability and cutting-edge technology, Primech Holdings integrates eco-friendly practices and smart technology solutions to enhance operational efficiency and client satisfaction. This strategic approach positions Primech Holdings as a leader in the industry and a proactive contributor to advancing industry standards and practices in Singapore and beyond. For more information, visit www.primechholdings.com.    

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements, including, for example, statements about completing the acquisition, anticipated revenues, growth, and expansion. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements are also based on assumptions regarding the Company’s present and future business strategies and the environment in which the Company will operate in the future. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

    Company Contact:
     Email: ir@primech.com.sg

    Investor Relations Contact:        
    Matthew Abenante, IRC
    President
    Strategic Investor Relations, LLC
    Tel: 347-947-2093
    Email: matthew@strategic-ir.com

    The MIL Network –

  • MIL-OSI: Primech A&P, a Subsidiary of Primech Holdings, Secures Major Contract Extension Worth Over $8.3 Million

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, July 08, 2025 (GLOBE NEWSWIRE) — Primech A & P, a subsidiary of Primech Holdings Limited (the “Company”) (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, today announced a 2-year contract extension valued at S$10,650,000 (US$8.3 million) providing comprehensive cleaning services at a renowned institution in Singapore.

    This contract renewal, a significant revenue contribution for Primech Holdings’ award-winning facility services subsidiary, reinforces Primech A & P’s competitive positioning in Singapore’s institutional cleaning market. Primech A & P’s proven track record of delivering reliable, high-touch facilities services enabled the Company to retain major institutional clients and generate predictable, recurring revenue streams.

    Ken Chang, Head of Operations at Primech A & P, stated, “This S$10.65 million contract extension validates our strategic focus on high-value institutional partnerships and demonstrates the strength of our service delivery model. The client’s decision to renew for an additional two years provides us with strong revenue visibility and reflects our ability to exceed performance expectations consistently. Primech A & P is a trusted partner in Singapore’s premium facility services market, and contract wins such as this support our continued growth trajectory.”

    About Primech Holdings Limited
     
    Headquartered in Singapore, Primech Holdings Limited is a leading provider of comprehensive technology-driven facilities services, predominantly serving both public and private sectors throughout Singapore. Primech Holdings offers an extensive range of services tailored to meet the complex demands of its diverse clientele. Services include advanced general facility maintenance services, specialized cleaning solutions such as marble polishing and facade cleaning, meticulous stewarding services, and targeted cleaning services for offices and homes. Known for its commitment to sustainability and cutting-edge technology, Primech Holdings integrates eco-friendly practices and smart technology solutions to enhance operational efficiency and client satisfaction. This strategic approach positions Primech Holdings as a leader in the industry and a proactive contributor to advancing industry standards and practices in Singapore and beyond. For more information, visit www.primechholdings.com.    

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements, including, for example, statements about completing the acquisition, anticipated revenues, growth, and expansion. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements are also based on assumptions regarding the Company’s present and future business strategies and the environment in which the Company will operate in the future. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

    Company Contact:
     Email: ir@primech.com.sg

    Investor Relations Contact:        
    Matthew Abenante, IRC
    President
    Strategic Investor Relations, LLC
    Tel: 347-947-2093
    Email: matthew@strategic-ir.com

    The MIL Network –

  • MIL-OSI: Correction: Form 8.3 – Unite Group Plc

    Source: GlobeNewswire (MIL-OSI)

    AMENDED DISCLOSURE – PLEASE REFER TO SECTION 3(a)

    8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: Rathbones Group Plc
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		  
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 The Unite Group Plc
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 03/07/2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 Yes

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 25p Ord
      Interests Short positions
      Number % Number %
    (1)   Relevant securities owned and/or controlled: 724,161 0.14%    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        

            TOTAL:

    		 724,161 0.14%    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    25p Ordinary Shares Sale 500 823.6449p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
             

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
                   

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit
             

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
           

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
    None

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”
    None

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? No
    Date of disclosure: 08/07/2025
    Contact name: Chinwe Enyi – Compliance Department
    Telephone number: 0151 243 7053

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at.

    The MIL Network –

  • MIL-OSI: Xsolis’ AI-Driven Solution, New Features Evaluated in KLAS Second Look Report

    Source: GlobeNewswire (MIL-OSI)

    FRANKLIN, Tenn., July 08, 2025 (GLOBE NEWSWIRE) — Xsolis, an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers, was featured today in the KLAS Second Look Report, “Xsolis Platform 2025: Improving Utilization Management, Length of Stay & Denial Performance Through AI-Driven Offerings in the Mid-Revenue Cycle.” The KLAS Second Look Report focuses on how the customer experience has changed over the past four years, including as a result of enhancements made available within Dragonfly, the next generation of the company’s AI-driven platform.

    KLAS is an independent research organization that helps healthcare providers make informed technology decisions by offering accurate, honest, and impartial vendor performance information. KLAS interviewed Xsolis clients in early 2025 for a second look, and reports the following anonymized key findings:

    • Respondents report satisfaction within the Key Performance Indicators:
      • Supports integration goals
      • Product has needed functionality (delivers solutions as expected)
      • Executive involvement
      • Likely to recommend
    • 89% of KLAS-surveyed customers report using Xsolis’ AI technology to minimize preventable denials
    • 91% of respondents say they are Satisfied or Highly Satisfied with Overall Performance
    • 88% of respondents say they saw outcomes Immediately, Within 6 Months, or Within 6-12 Months
    • 78% engage in payer-provider communications through the Dragonfly platform
    • Respondents who have been on Xsolis’ AI-driven platform for more than one year report excitement about new updates and functionalities that are being offered as a result of Dragonfly
    • Respondents report the top reasons they selected the Xsolis platform as: advanced AI technology, excellent customer service, seamless EHR integration, and positive references
    • Respondents say the Xsolis platform has reduced the length of patient stays, saved on costs, and improved observation rates and denials rates

    “What has changed with our most recent KLAS survey effort is our expanded footprint and the problems Xsolis solves, including optimizing length-of-stay and increasing payer-provider collaboration, which have been critical in bringing relief to our clients,” said Joan Butters, CEO and co-founder of Xsolis. “As we enhance our solutions to deliver frictionless healthcare in meaningful, new ways for our clients, it is both validating and informative to learn their feedback as we continue to meet their evolving needs.”

    A Kaiser Family Foundation survey from 2023 revealed claims denials are up, with nearly one in five adults experiencing health insurance claim denials in the previous year. Adjudicating denials costs just under $20 billion a year, and around half of denials are ultimately overturned — a costly problem that can be improved with tools that accelerate payer-provider alignment. Late 2024 marked an inflection point for payer-provider friction and how it affects the patient experience, accelerating the need for transparency and reform.

    Xsolis was featured in a KLAS Top 20 Emerging Solutions Report and as one of the top five solutions for reducing the cost of care in 2022 and was listed in 2025 as No. 1 Best in KLAS for Physician Advisory Services for the fourth year. A payer client’s and provider client’s use of Xsolis’ shared platform was recognized in a 2023 KLAS Points of Light Case Study, which highlights successful payer-provider initiatives that lead to an improved patient experience.

    As a pioneer in the practical, effective application of AI in healthcare, Xsolis has been helping its clients make more informed medical necessity decisions during utilization reviews since 2013. Dragonfly represents the next generation of the company’s AI-driven platform and was launched in late 2024. The platform is powered by Predictive AI models, offers new Generative AI tools, and can be augmented with advanced analytic packages such as Navigate to reduce length of stay or Revenue Integrity Insights. Xsolis also offers Denials Management Services and Physician Advisory Services. To date, Xsolis’ solutions are used in more than 500 hospitals nationwide, with two-thirds having shared AI platform access with their networked health plans.

    To learn more about Xsolis, please visit: www.xsolis.com

    Download the KLAS Second Look Report here: https://www.xsolis.com/2025-klas-second-look-report/

    KLAS subscribers can access the report here: https://klasresearch.com/report/xsolis-platform-2025-improving-utilization-management-length-of-stay-and-denial-performance-through-ai-driven-offerings-in-the-mid-revenue-cycle/3746

    About Xsolis
    Xsolis is an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers. Dragonfly®, its AI-driven proprietary platform, is the first and only solution to use real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient, enabling more efficiency across the healthcare system. Xsolis is headquartered in Franklin, Tennessee. For more information, visit www.xsolis.com.

    About KLAS
    KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at klasresearch.com.

    The MIL Network –

  • MIL-OSI: BlockchainCloudMining Launches New Short-Term Contracts to Help Investors Capitalize on Crypto Market Volatility

    Source: GlobeNewswire (MIL-OSI)

    Miami, Florida, July 08, 2025 (GLOBE NEWSWIRE) — In response to a crypto market navigating a complex new cycle, BlockchainCloudMining, a leading global cloud mining platform, today announced the launch of a new suite of short-term, high-yield mining contracts. The new offerings are specifically designed to provide investors with a stable and predictable way to generate returns from their crypto assets amidst ongoing market volatility.

    The move comes as investors are shifting from speculative trading to more sustainable, long-term strategies. By offering contracts with fixed returns and short durations, BlockchainCloudMining aims to provide a low-risk channel for individuals to put their idle crypto assets to work. To encourage trial, the company is offering an instant $12 bonus to all new users upon registration.

    “Investors are moving beyond speculation and are now seeking sustainable value from their digital assets,” said the spokesperson for BlockchainCloudMining. “Our new short-term contracts are a direct answer to this demand. We are providing a transparent, low-risk channel for individuals to earn daily returns without the need for hardware or exposure to extreme market sentiment.”

    The new contracts are available immediately and offer several key advantages:

    • High Profitability: Designed for strong, predictable returns with dividends paid within 24 hours.
    • No Hidden Fees: The platform charges no management or service fees on its contracts.
    • Multi-Currency Support: Accepts deposits and pays out in over nine popular cryptocurrencies, including BTC, ETH, DOGE, SOL, USDC, USDT, XRP, LTC, and BCH.
      • Robust Security: The platform is protected by McAfee® and Cloudflare®, ensuring secure transactions and data protection with a 100% uptime guarantee.
      • Referral Program: A generous affiliate program allows users to earn up to $50,000 in referral bonuses.

    The new contract tiers launched today include:

    Contract Plan Investment Duration Total Payout
    WhatsMiner M66S $ 100 2 Days $ 106
    WhatsMiner M60 $ 500 7 Days $ 545.50
    Bitcoin Miner S21+ $ 1,000 14 Days $ 1,196
    ALPH Miner AL1 $ 3,000 20 Days $ 3,900
    ANTSPACE HK3 $ 10,000 35 Days $ 15,950
    Full Details on Site $ 33,000 40 Days $ 59,400

    Users can register for an account with an email address and purchase a contract to begin mining immediately. Payouts are delivered daily and can be withdrawn to a personal crypto wallet or reinvested into new contracts blockchian to compound returns.

    About BlockchainCloudMining:

    BlockchainCloudMining is a premier global platform for cryptocurrency cloud mining. The company provides a secure and transparent way for users to mine cryptocurrencies like Bitcoin, Dogecoin, and Litecoin through a global network of green energy-powered data centers. With a commitment to security and a 100% uptime guarantee, the platform helps investors worldwide convert idle assets into a continuous income stream.

    For more information or to register for an account, please visit the official website – https://blockchaincloudmining.com/xml/index.html#/

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    The MIL Network –

  • MIL-OSI: Top Las Vegas Loan Officer Leaves CrossCountry Mortgage, Boomerangs Back to Rate

    Source: GlobeNewswire (MIL-OSI)

    LAS VEGAS, July 08, 2025 (GLOBE NEWSWIRE) — Rate, a leading fintech company, today announced the return of top-producing Las Vegas loan originator Jia Mei Wang, who has officially boomeranged back to the company after a stint at CrossCountry Mortgage.

    A seasoned mortgage professional since 2003, Wang originally spent six years with Rate before exploring other platforms. She now returns, citing the company’s unmatched technology and end-to-end support.

    “After spending over half a decade at Rate in years prior, I was confident returning would be the right move,” said Wang. “The company’s technology platform makes it easier to close loans efficiently, which is critical when you’re focused on building long-term client relationships.”

    In addition to her career as a loan originator, Wang is also President of the North America Shanghai Chamber of Commerce. Her decision to rejoin reflects the company’s continued strength in attracting and retaining top-tier talent focused on growth, service, and community leadership.

    “Jia Mei is one of the top-producing loan officers in Las Vegas, and we’re excited to have her back,” said John Stewart, Rate Chief Production Officer, West. “She’s sharp, experienced, and deeply committed to her clients. She knows what it takes to deliver, and we’re proud to support her as she serves clients in Las Vegas and beyond.”

    Her return expands Rate’s presence in Las Vegas and reinforces the company’s commitment to supporting high-performing originators with the tools, coaching, and infrastructure to thrive.

    About Rate

    Rate Companies is a leader in mortgage lending and digital financial services. Headquartered in Chicago, Rate has over 850 branches across all 50 states and Washington, D.C. Since its launch in 2000, Rate has helped more than 2 million homeowners with home purchase loans, refinances, and home equity loans. The company has cemented itself as an industry leader by introducing innovative technology, offering low rates, and delivering unparalleled customer service. Recent honors and awards include: a Best Mortgage Lender of 2025 by Fortune; Best Mortgage Lender of 2025 for First-Time Homebuyers by Forbes; a Best Mortgage Lender of 2025 for FHA Loans, Home Equity Loans, and Lower Credit Scores by NerdWallet; Best Mortgage Lender of 2025 for Digital Experience and Down Payment Assistance by Motley Fool; Chicago Agent Magazine’s Lender of the Year for seven consecutive years. Visit rate.com for more information.

    Contact

    press@rate.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d70400a2-ae37-4214-a50b-87ba39f77f09

    The MIL Network –

  • MIL-OSI: Gevo to Participate in Virtual Fireside Chat

    Source: GlobeNewswire (MIL-OSI)

    ENGLEWOOD, Colo., July 08, 2025 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) announced today that Leke Agiri, Gevo’s Chief Financial Officer, and Eric Frey, Gevo’s Vice President of Finance and Strategy, will participate in a virtual fireside chat on Wednesday, July 9, 2025 at 10:00am ET.

    Investors and other persons interested in participating in the event must register using the link below.

    Registration Link: https://www.renmarkfinancial.com/live-registration/renmark-virtual-non-deal-roadshow-nasdaq-gevo-LDnER-DQV-

    About Gevo

    Gevo is a next-generation diversified energy company committed to fueling America’s future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Gevo’s innovative technology can be used to make a variety of renewable products, including synthetic aviation fuel (“SAF”), motor fuels, chemicals, and other materials that provide U.S.-made solutions. By investing in the backbone of rural America, Gevo’s business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates one of the largest dairy-based renewable natural gas (“RNG”) facilities in the United States, turning by-products into clean, reliable energy. We also operate an ethanol plant with an adjacent carbon capture and sequestration (“CCS”) facility, further solidifying America’s leadership in energy innovation. Additionally, Gevo owns the world’s first production facility for specialty alcohol-to-jet (“ATJ”) fuels and chemicals. Gevo’s market-driven “pay for performance” approach regarding carbon and other sustainability attributes, helps ensure value is delivered to our local economy. Through its Verity subsidiary, Gevo provides transparency, accountability, and efficiency in tracking, measuring and verifying various attributes throughout the supply chain. By strengthening rural economies, Gevo is working to secure a self-sufficient future and to make sure value is brought to the market.

    For more information, see www.gevo.com.

    Media Contact
    Heather Manuel
    Vice President of Stakeholder Engagement & Partnerships
    PR@gevo.com

    Investor Contact
    Eric Frey, PhD
    Vice President of Finance and Strategy
    IR@Gevo.com

    The MIL Network –